EUVIMEDEUVIMED entdecken
Leserbrief

Autoimmune cerebellar ataxia associated with anti-SEZ6L2 antibody: report of three cases

Mange Liu, Haitao Ren, Dongpi Yao, Ming Yao, Nan Jiang, Siyuan Fan, Hongzhi Guan

Journal of Neurology · 2025-02 · 272 (2)

DOI: 10.1007/s00415-024-12756-9 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Neurology, online erschienen am 15.01.2025. Verfasst von Mange Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking Union Medical College Hospital, Beijing, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Funding.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Neurology, Peking Union Medical College Hospital, Beijing, China.
  • Department of Neurology, Beijing Chaoyang Integrative Medicine Rescue and First Aid Hospital, Beijing, China.
  • Department of Neurology, Peking Union Medical College Hospital, Beijing, China. guanhz@263.net.

Förderung

  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Liu, M., Ren, H., Yao, D., Yao, M., Jiang, N., Fan, S., & Guan, H. (2025). Autoimmune cerebellar ataxia associated with anti-SEZ6L2 antibody: report of three cases. Journal of Neurology, 272(2). https://doi.org/10.1007/s00415-024-12756-9

Vancouver

Liu M, Ren H, Yao D, Yao M, Jiang N, Fan S, et al. Autoimmune cerebellar ataxia associated with anti-SEZ6L2 antibody: report of three cases. Journal of Neurology. 2025;272(2). doi:10.1007/s00415-024-12756-9

BibTeX
@article{Liu2025,
  author = {Liu, Mange and Ren, Haitao and Yao, Dongpi and Yao, Ming and Jiang, Nan and Fan, Siyuan and Guan, Hongzhi},
  title = {Autoimmune cerebellar ataxia associated with anti-SEZ6L2 antibody: report of three cases},
  journal = {Journal of Neurology},
  year = {2025},
  volume = {272},
  number = {2},
  doi = {10.1007/s00415-024-12756-9}
}
Kostenlos starten →